FOSUN HEALTH Logo

Bone Metastasis Overview

catalogue

Bone Metastasis Overview

Bone Metastasis Overview

Bone metastasis means a cancer that began somewhere else in the body has spread to bone. It is not a new cancer, and it is not bone cancer: the cells in the bone are cells of the original tumour that travelled through the bloodstream and settled there. That single fact shapes everything — what the pain means, why the treatment of the original cancer remains the foundation, and why the skeleton itself has to be protected alongside it.

Bone Metastasis Overview
  • the cells in the bone belong to the original tumour — the treatment of that cancer stays central

  • persistent, often worse at night or at rest, and felt at a point rather than spread across a region

  • pressure on the spinal cord and a raised calcium level — both need same-day assessment, not a wait

  • from complete records to a personalized MDT plan

What bone metastasis is

Bone metastasis is cancer that began somewhere else and has spread to bone. The cells that make up a deposit in bone are cells of the original tumour — breast, lung, prostate, kidney, thyroid or another organ. They reached the bone through the bloodstream, settled in the bone marrow, and grew there. Two common misunderstandings follow directly from this, and both are worth correcting at the outset. Bone metastasis is not a new cancer: it is the original cancer, in a new place, and it is treated as such. And it is not bone cancer, which is a rarer disease that begins in the bone itself and behaves quite differently.

The importance of that distinction is practical rather than semantic. Because the cells are the original cancer's cells, the treatment that works against that cancer still works against its deposits in bone — a breast cancer deposit in the spine is treated with the drugs that treat breast cancer. And because the bone is a living tissue that is continuously broken down and rebuilt, a deposit interferes with that cycle: it can dissolve the bone around it, thicken it, or do both at once. The consequences are the ones patients feel — pain, a bone that breaks too easily, pressure on the spinal cord when a deposit sits in the spine, and a raised calcium level when the bone is being broken down faster than the body can handle.

The aim of treatment is therefore not the bone alone. It combines the treatment that is directed at the original cancer — hormonal treatment, targeted therapy, chemotherapy or immunotherapy, chosen by what that cancer is — with drugs that protect the skeleton, and with local measures such as radiotherapy, surgery or cement for the deposits that are causing a specific problem. Pain is treated properly and early rather than tolerated. The result is that bone metastasis is usually managed as a long-term condition, with the bone problem and the cancer problem handled together by one team.

Pain is the commonest reason a patient comes to a doctor, and it has a character that is worth knowing. It is usually persistent rather than intermittent, it is frequently worse at night or at rest than during the day, and it tends to be felt at a particular point rather than spread vaguely across a region. It does not settle with the measures that help ordinary muscular backache. That said, pain in a person who has had cancer is not automatically a sign of spread, and equally, pain that persists deserves to be looked at rather than explained away.

Two situations are emergencies and are treated as such. The first is pressure on the spinal cord by a deposit in the spine, which announces itself with back pain together with new weakness, numbness or tingling in the legs, difficulty walking, or a change in bladder or bowel control; if it is not relieved quickly, the weakness can become permanent. The second is a raised calcium level in the blood, which causes confusion, drowsiness, thirst, passing a lot of urine, nausea or constipation. Neither should wait for the next scheduled appointment, and both are reversible if they are dealt with early. A third situation — a bone that has broken, or is about to break — is urgent rather than emergent, and is usually anticipated and dealt with before it gives way.

Which cancers reach bone, and how the deposits behave

Bone is a well-supplied tissue, and many cancers can reach it. A small number of primary cancers account for most bone metastases, and knowing which one is involved matters because it is that cancer, and not the bone, that determines the drugs used:

Common primary cancers What is established
Breast One of the cancers most likely to involve bone, and one where bone deposits often appear years after the original treatment; hormone receptor and HER2 status guide the systemic treatment
Prostate Commonly involves bone, usually as dense rather than dissolving deposits, and is treated with hormonal therapy and with drugs that protect the skeleton
Lung A frequent source, and one where the markers on the tumour — EGFR, ALK, PD-L1 — may open the door to targeted or immune treatment
Kidney Produces deposits that tend to bleed and to dissolve bone, so surgery and embolisation are used more often than in other cancers
Thyroid Involves bone in a proportion of patients and is treated with thyroid-specific systemic treatment where it is available
Others Many other cancers can reach bone, including bowel, stomach, bladder and the blood cancers; in each case the treatment follows the primary

Deposits are described by what they do to the bone, and that description is read on the imaging rather than assumed. A deposit that dissolves bone is called osteolytic and is the pattern typically seen with breast, lung, kidney and thyroid cancers. A deposit that thickens bone is called osteoblastic or sclerotic and is the pattern typical of prostate cancer. Many are mixed. The distinction matters for two reasons: it affects how the deposit looks on a scan and therefore how it is followed, and it affects the risk of fracture, since a bone that has been dissolved is mechanically weaker than one that has been thickened.

What should not be read into this list is that bone metastasis is a single disease with a single behaviour. A patient with one deposit in a rib and a patient with several deposits in the spine, pelvis and femur are in quite different situations, and they are treated differently — the first may need nothing more than the systemic treatment of the underlying cancer, and the second may need radiotherapy, protection of the skeleton, and possibly surgery. The plan is set by the whole picture, not by the diagnosis alone.

Extent: how much bone is involved, and where

There is no separate stage that describes a bone metastasis on its own. The cancer keeps the stage it already had, and the bone deposits are described by their extent and their distribution — how many bones are involved, which ones, and whether any of them threatens a specific structure. That description, together with the state of the original cancer, is what the treatment is built on:

What is described In plain terms What it means for the plan
Distribution Which bones are involved — spine, pelvis, ribs, upper femur, skull or elsewhere Determines whether the whole body needs surveying and which areas need watching on follow-up imaging
Number of deposits One deposit, a few, or widespread involvement of the skeleton A limited number may be treated locally; widespread involvement is treated mainly with systemic treatment and skeletal protection
Structural risk Whether a deposit has weakened the bone enough that it may break The reason prophylactic surgery or fixation is considered before a fracture happens, rather than after
Cord and roots Whether a deposit in the spine is touching or pressing on the spinal cord or nerve roots Any contact with the cord moves the patient to urgent imaging and, if confirmed, to treatment without delay
Other disease Whether the cancer is also present in organs such as the liver, lungs or lymph nodes Bone is treated alongside the rest of the disease, not in isolation from it
Calcium Whether the bone breakdown has raised the calcium in the blood A raised level is corrected as a medical emergency and then kept under control

What the tissue test of the original cancer adds

Treatment for bone metastasis is selected by what the original cancer is, not by the bone deposit as though it were a separate disease. That means the pathology of the primary tumour — and, where it is available, of a deposit — is what directs the systemic treatment:

Marker What it is What it means in practice
Hormone receptors Oestrogen and progesterone receptors, tested in breast cancer When present, hormonal treatment is a mainstay and can control bone deposits for long periods
HER2 A receptor that can be over-expressed in breast and some other cancers When present, targeted treatment against HER2 is used, and it is effective against the deposits as well
EGFR / ALK Driver changes found in a proportion of lung cancers When present, targeted tablets can control the disease, including bone deposits, without chemotherapy
PD-L1 A protein used to judge whether immune treatment is likely to help Tested on tissue that already exists; it can open an immune-based route in several cancer types
PSA and hormones The markers used in prostate cancer Guide hormonal treatment, which is the backbone of treatment for prostate cancer in bone
Re-biopsy A fresh sample of a deposit, where the disease has changed Sometimes needed because a cancer can alter its markers over time, and the change alters the treatment

Why patients come to China for bone metastasis care

The care of bone metastasis is decided by a set of capabilities that have to work together, and it is the combination rather than any single one that a patient comes for:

  • A plan that treats the cancer and the bone together — medical oncology and the team managing the skeleton working from one plan, rather than a bone problem referred away from the cancer problem.
  • Bone-modifying treatment given properly and monitored — a bisphosphonate or denosumab on a defined schedule, with calcium, vitamin D and kidney function and with dental assessment before treatment starts, since that is where the complications are prevented.
  • Radiotherapy delivered promptly for pain and for the cord — a short course or a single treatment to a painful deposit, and urgent treatment to the spine where the cord is threatened, without waiting for a routine slot.
  • Surgery that stabilises rather than removes — internal fixation, joint replacement, spinal decompression with instrumentation, and cement augmentation such as vertebroplasty or kyphoplasty, offered where the deposit is the problem rather than assuming it cannot be operated on.
  • Interventional radiology where it helps — embolisation and ablation of deposits that bleed or resist other treatment, used in the types of cancer where that is established practice.
  • Pain controlled by design — analgesia planned with the oncologist from the start, including adjuvants for nerve pain, rather than added when the patient complains.
  • Rehabilitation that keeps people mobile — physiotherapy, bracing and a plan to prevent falls, together with attention to calcium and vitamin D, because staying on the feet is part of the treatment.
  • One multidisciplinary review, and one written plan — the imaging, the pathology and the patient's priorities reviewed at the same meeting, with the plan set out in writing before treatment starts.

Because bone metastasis is usually managed over months and years rather than weeks, patients who live elsewhere commonly come for the assessment and an initial plan, then return home with a written schedule that a local team can follow, and come back when a specific problem needs treating. The records that make that possible are the original pathology report in full with any receptor and marker results, the imaging of the bone deposits with its reports and dates, the record of treatments already given for the original cancer, and the current medication list including any pain relief. Send those, and the written assessment is returned within 48 hours of the file being complete.

Frequently Asked Questions

Does bone metastasis mean the cancer is at its end?

No, and treating it that way would close off the treatment that helps most. A bone deposit means the cancer has spread beyond where it started, which does change the aim of treatment — the cancer is managed rather than removed — but it does not mean there is nothing to be done. Many cancers that involve bone can be controlled for long periods with systemic treatment chosen for that cancer, and the bone itself is protected with drugs, radiotherapy, surgery or cement depending on what each deposit is doing. The practical effect is that bone metastasis is usually treated as a long-term condition, and a substantial part of the treatment is directed at keeping a person mobile, comfortable and living normally rather than at the cancer alone.

Is bone metastasis the same as bone cancer?

No, and they are different diseases that happen to be in the same place. Bone cancer — osteosarcoma, for example — begins in the bone's own cells. Bone metastasis is cancer that began elsewhere and spread to bone, so the cells in the bone are those of the original tumour. The distinction is not academic: it decides which drugs are used, because the treatment is directed at the original cancer. A breast cancer that has spread to the spine is treated with the treatments that work against breast cancer, and the bone is protected alongside. This is why the pathology report of the original tumour, rather than the bone itself, is the document that guides treatment.

What should make me go to hospital straight away?

Two things, and neither should wait for a scheduled appointment. The first is back pain together with new weakness, numbness or tingling in the legs, difficulty walking, or a change in bladder or bowel control — that combination suggests a deposit is pressing on the spinal cord, and the weakness can become permanent if it is not relieved quickly. The second is confusion or drowsiness together with thirst, passing a lot of urine, nausea or constipation, which suggests a raised calcium level in the blood. Both are treatable and both are straightforward to assess, with an MRI for the first and a blood test for the second. Ringing the oncology team or going to an emergency department is the right response in each case; waiting to see whether it settles is not.

Can a bone that has been weakened by a deposit be fixed before it breaks?

Often, yes, and that is the reason deposits are monitored with attention to structure rather than only to pain. If a deposit has destroyed enough of a load-bearing bone — most often the upper femur or a vertebra — the risk of a fracture can be judged from the imaging, and surgery to stabilise the bone can be planned before it gives way rather than after. Fixation or a joint replacement for the hip, or cement augmentation for a painful vertebra, are the usual routes, followed by radiotherapy to the area and by rehabilitation. This is worth asking about directly, because a bone that is stabilised before it breaks is a far easier problem than one that has already broken.

Patient Stories

Stories from our bone metastasis programme, pulled automatically from the patient story library by disease tag.

View all patient stories →

Send the pathology, the scans and the medication list, get a written plan

Upload the original pathology report in full including receptor and marker results, the imaging of the bone deposits with its reports and dates, the record of treatments already given for the original cancer, and the current medication list including pain relief. Our team will return a written assessment within 48 hours of the file being complete, setting out how the underlying cancer would be treated, how the skeleton would be protected, which deposits would need radiotherapy, surgery or cement and in what order, and what the follow-up schedule would be.

Want to see the whole process first? Your full medical journey, step by step →

Book an Appointment Request a Video Consultation

Follow Fosun Health

Apply for an Appointment

Do you have test results*